Add time:08/01/2019         Source:sciencedirect.com

Thorium incorporation in the rhabdophane (cas 12174-41-3) structure as Pr1-2xCaxThxPO4·nH2O solid solutions was successfully achieved and resulted in the preparation of a low temperature precursor of the monazite-cheralite type Pr1-2xCaxThxPO4. The rhabdophane compounds are considered as potential neoformed phases in case of release of actinides from the phosphate-based ceramic wasteforms envisaged to host radionuclides in the back-end of the nuclear fuel cycle. A multiparametric study was thus undertaken to specify the wet chemistry conditions (starting stoichiometry, temperature, heating time) leading to single phase Pr1-2xCaxThxPO4·nH2O powdered samples. The excess of calcium appeared to be a prevailing factor with a suggested initial Ca:Th ratio being equal to 10. Similarly, the recommended heating time should exceed 4 days while the optimal temperature of synthesis is 110 °C. Under these conditions, the stability domain of Pr1-2xCaxThxPO4·nH2O ranged from x = 0.00 to x = 0.15. After heating at 1100 °C under air during 6 h, rhabdophane-type samples were fully converted into the highly durable Pr1-2xCaxThxPO4 cheralite ceramic wasteform.

We also recommend Trading Suppliers and Manufacturers of rhabdophane (cas 12174-41-3). Pls Click Website Link as below: cas 12174-41-3 suppliers